Vesicular
monoamine transporter 2 (VMAT2) uptakes cytoplasmic monoamines into vesicles for
storage. VMAT2 plays a role in modulating insulin release by regulating
dopamine levels in the pancreas, although the exact mechanism remains elusive. We
found that VMAT2 expression in beta-cells specifically increases under high
blood glucose conditions. The islets isolated from beta-cell specific Vmat2 knock-out (βVmat2KO) mice show elevated
insulin secretion levels in response to glucose stimulation. Under prolonged high-fat diet feedings, the βVmat2KO
mice exhibit impaired
glucose and insulin tolerance and progressive beta-cell dysfunction. We
demonstrate here that VMAT2 uptakes dopamine to protect it from degradation by
monoamine oxidase, thereby safeguarding beta-cells from excess reactive oxygen
species (ROS) exposure. When under high demand for insulin secretion, the
absence of VMAT2 leads to elevated ROS in beta-cells, which accelerates beta-cell
dedifferentiation and beta-cell loss. Therefore, VMAT2 controls the amount of
dopamine in beta-cells thereby protecting pancreatic beta-cells from excessive
oxidative stress.
Funding
This work was supported by a grant from the Project for Realization of Regenerative Medicine from Japan Agency for Medical Research and Development (AMED) under Grant Number (17bm0704004h0101). Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology, Japan (#18H02861 to SK and #17K09455 to DS). This work was also supported in part by the Takeda Science Foundation, Japan Insulin Dependent Diabetes Mellitus (IDDM) Network.